16-April-2024

Tourmaline Bio Director Acquires 20,500 Shares After Exercising Company Stock Options

Grand News Network | October 24, 2023

Sapna Srivastava, Director at Tourmaline Bio (NASDAQ:TRML), reported a large exercise of company stock options on October 24, according to a new SEC filing.

What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Tuesday showed that Srivastava, Director at Tourmaline Bio, a company in the Health Care sector, just exercised stock options worth 20,500 shares of TRML stock with an exercise price of $2.54.

Tourmaline Bio shares are trading up 5.71% at $10.0 at the time of this writing on Tuesday morning. Since the current price is $10.0, this makes Srivastava's 20,500 shares worth $205,000.

Now trade stocks online commission free with Charles Schwab, a ...

Full story available on Benzinga.com


Disclaimer: The views, recommendations, and opinions expressed in this content belong solely to the third-party experts. This site was not involved in the writing and production of this article.


Disclaimer Press Release Banner